middle.news
Anatara Lifesciences Secures $969K Boost for Anti-Obesity Research
11:01am on Monday 28th of July, 2025 AEST
•
Healthcare
Read Story
Anatara Lifesciences Secures $969K Boost for Anti-Obesity Research
11:01am on Monday 28th of July, 2025 AEST
Key Points
Received $969,455.79 R&D tax incentive refund for FY25
Funds earmarked to progress Anti-Obesity pre-clinical Proof of Concept studies
R&D tax incentive offers 43.5% cash rebate on qualifying research activities
Supports Anatara’s focus on gastrointestinal tract-related health innovations
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Anatara Lifesciences (ASX:ANR)
OPEN ARTICLE